FDA issues an Early Communication about an Ongoing Safety Review of clopidogrel bisulfate (marketed as Plavix)
This is a discussion on FDA issues an Early Communication about an Ongoing Safety Review of clopidogrel bisulfate (marketed as Plavix) within the FDA News forum, part of the Industry News and Updates category; FDA issues an Early Communication about an Ongoing Safety Review of clopidogrel bisulfate (marketed as Plavix) More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
01-26-2009, 01:09 PM
|
|||
|
|||
FDA issues an Early Communication about an Ongoing Safety Review of clopidogrel bisulfate (marketed as Plavix)
FDA issues an Early Communication about an Ongoing Safety Review of clopidogrel bisulfate (marketed as Plavix)
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Follow-up to the January 25, 2008 Early Communication about an Ongoing Data Review for Ezetimibe/Simvastatin (marketed a | industry_news | FDA News | 0 | 01-08-2009 04:32 PM |
| FDA issues an updated Early Communication about an Ongoing Safety Review of Tiotropium (marketed as Spiriva HandiHaler). | industry_news | FDA News | 0 | 10-07-2008 11:37 AM |
| FDA issues an Early Communication About an Ongoing Safety Review of Vytorin, Zocor, and Zetia. | industry_news | FDA News | 0 | 08-22-2008 03:44 PM |
| FDA issues an Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Re | industry_news | FDA News | 0 | 06-07-2008 07:30 PM |
| FDA issues an Early Communication about an Ongoing Safety Review for Botox | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |